Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

Status Not yet recruiting

Clinical Trial Summary

This study was a prospective, multicenter, single-arm clinical study planned to enroll 60 patients who developed hemorrhagic cystitis after sexually allogeneic hematopoietic stem cell transplantation Patients with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation were given symptomatic supportive treatment combined with moxibustion covering Shenque, Zhongguo, Guanyuan, and Qihai for 30 minutes every day for 14 days and urine routine was collected every day for 14 days to assess the severity of hemorrhagic cystitis and pain scores to evaluate the effectiveness of moxibustion in treating hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cystitis
Hematopoietic Stem Cell Transplantation
Hemorrhagic Cystitis
Moxibustion
Treatment

Clinical Trial Details

NCT number	NCT06241274
Study type	Interventional
Source	Wuhan Union Hospital, China
Contact	Yi Zhang
Phone	+86 15639790587
Email	zy188603@163.com
Status	Not yet recruiting
Phase	N/A
Start date	January 25, 2024
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00766883` - Problem-Solving Education for Caregivers and Patients During Stem Cell Transplant	Phase 2
Recruiting	`NCT06148610` - Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Recruiting	`NCT04690933` - AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients
Completed	`NCT02564458` - Fitness in Allogeneic Stem Cell Transplantation	N/A
Recruiting	`NCT02543073` - MSC for Treatment of Interstitial Lung Disease After Allo-HSCT	Phase 1/Phase 2
Not yet recruiting	`NCT01714557` - Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation	N/A
Completed	`NCT00701688` - Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation	Phase 1
Completed	`NCT00023530` - Blood and Marrow Transplant Clinical Research Network	N/A
Recruiting	`NCT04092309` - Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation	N/A
Completed	`NCT00000603` - Cord Blood Stem Cell Transplantation Study (COBLT)	Phase 2
Completed	`NCT02663622` - Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)	Phase 2
Recruiting	`NCT04937634` - Pharmacokinetic Study of Melphalan in Pediatric Hematopoietic Stem Cell Transplantation	Phase 1
Recruiting	`NCT04203108` - ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis	Phase 4
Completed	`NCT03654599` - Effects of Digital Stories Intervention on Psychosocial Well-being	N/A
Withdrawn	`NCT03279133` - Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients.	Phase 4
Completed	`NCT05151406` - Myths and Misconceptions About HSCT in a Limited Resource Region	N/A
Completed	`NCT02241005` - Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci	N/A
Recruiting	`NCT03689465` - PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis	Phase 4
Recruiting	`NCT04868786` - Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplantation	Phase 1
Recruiting	`NCT03010579` - Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation	Phase 4